Steven P. Tanis

1.9k total citations
45 papers, 1.2k citations indexed

About

Steven P. Tanis is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Steven P. Tanis has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Organic Chemistry, 17 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Steven P. Tanis's work include Chemical synthesis and alkaloids (8 papers), Asymmetric Synthesis and Catalysis (7 papers) and Metabolism, Diabetes, and Cancer (6 papers). Steven P. Tanis is often cited by papers focused on Chemical synthesis and alkaloids (8 papers), Asymmetric Synthesis and Catalysis (7 papers) and Metabolism, Diabetes, and Cancer (6 papers). Steven P. Tanis collaborates with scholars based in United States and Kenya. Steven P. Tanis's co-authors include Koji Nakanishi, Paul M. Herrinton, Jerry R. Colca, Mark C. McMills, Jeffrey W. Raggon, Hiroyuki Akita, Michael Adams, Valeria Balogh‐Nair, David J. Hart and David A. Evans and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Steven P. Tanis

44 papers receiving 1.2k citations

Peers

Countries citing papers authored by Steven P. Tanis

Since Specialization

Citations

This map shows the geographic impact of Steven P. Tanis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven P. Tanis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven P. Tanis more than expected).

Fields of papers citing papers by Steven P. Tanis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven P. Tanis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven P. Tanis. The network helps show where Steven P. Tanis may publish in the future.

Co-authorship network of co-authors of Steven P. Tanis

This figure shows the co-authorship network connecting the top 25 collaborators of Steven P. Tanis. A scholar is included among the top collaborators of Steven P. Tanis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven P. Tanis. Steven P. Tanis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design and Evaluation of Biodegradable Self‐Immolative Lipids for RNA Delivery 2025 ·Advanced Healthcare Materials ·Rajesh Mukthavaram, Amit Sagi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Cristiano Sacchetti, Steven P. Tanis, Priya Karmali, (unknown), (unknown)	0
2	Synthesis and bioactivity of readily hydrolysable novel cationic lipids for potential lung delivery application of mRNAs 2022 ·Chemistry and Physics of Lipids ·Yihua Pei, Yanjie Bao, Cristiano Sacchetti, (unknown), (unknown), Hailong Yu, Scott Roberts, (unknown), Steven P. Tanis, Carlos G. Pérez‐García, Padmanabh Chivukula, Priya Karmali	18
3	Property-Driven Design and Development of Lipids for Efficient Delivery of siRNA 2020 ·Journal of Medicinal Chemistry ·(unknown), Steven P. Tanis, Rajesh Mukthavaram, Scott Roberts, Michelle Nguyen, Kiyoshi Tachikawa, Amit Sagi, Marciano Sablad, Pattraranee Limphong, (unknown), Hailong Yu, Padmanabh Chivukula, Joseph E. Payne, Priya Karmali	27
4	PPARγ-sparing thiazolidinediones as insulin sensitizers. Design, synthesis and selection of compounds for clinical development 2018 ·Bioorganic & Medicinal Chemistry ·Steven P. Tanis, Jerry R. Colca, (unknown), Gerald D. Artman, Scott D. Larsen, William Graham McDonald, Robert C. Gadwood, Rolf F. Kletzien, (unknown), Pil H. Lee, Wade J. Adams	8
5	The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase 2010 ·Bioorganic & Medicinal Chemistry Letters ·Steven P. Tanis, Joseph W. Strohbach, (unknown), (unknown), Suvit Thaisrivongs, (unknown), Todd A. Hopkins, Mary L. Knechtel, Nancee L. Oien, (unknown), (unknown), Michael W. Wathen	15
6	Novel synthesis of CP-734432, an EP4 agonist, using Sharpless asymmetric dihydroxylation 2009 ·Tetrahedron Letters ·Sajiv K. Nair, (unknown), (unknown), Chunrong Ma, (unknown), Alan W. Grubbs, Neal W. Sach, Wolter ten Hoeve, (unknown), (unknown), Steven P. Tanis, Matt A. M. Renner, (unknown)	5
7	2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases 2007 ·Bioorganic & Medicinal Chemistry Letters ·Mark E. Schnute, David Anderson, Roger J. Brideau, Fred L. Ciske, Sarah A. Collier, (unknown), MariJean Eggen, Michaël Génin, Todd A. Hopkins, Thomas M. Judge, (unknown), Mary L. Knechtel, Sajiv K. Nair, James A. Nieman, Nancee L. Oien, (unknown), Steven P. Tanis, Valerie Vaillancourt, Michael W. Wathen, (unknown)	36
8	Synthesis and Biological Activity of Aminoguanidine and Diaminoguanidine Analogues of the Antidiabetic/Antiobesity Agent 3-Guanidinopropionic Acid 2001 ·Journal of Medicinal Chemistry ·Valerie Vaillancourt, Scott D. Larsen, Steven P. Tanis, (unknown), Mark A. Connell, (unknown), (unknown), (unknown), Paul D. May, Martin D. Meglasson, (unknown), Frits C. Stevens, John A. Tucker, Thomas J. Vidmar, (unknown)	42
9	Furan-Terminated N-Acyliminium Ion Initiated Cyclizations in Alkaloid Synthesis 1998 ·The Journal of Organic Chemistry ·Steven P. Tanis, (unknown), (unknown), Mark C. McMills, Jeffrey W. Raggon, Mark A. Collins	41
10	Furans in synthesis 101. An efficient construction of the bicyclo[5.3.0]decane ring system of fastigilin-C 1990 ·Tetrahedron Letters ·Steven P. Tanis, Mark C. McMills, Terrence A. Scahill, (unknown)	11
11	Furans in synthesis. 8. Formal total syntheses of (.+-.)- and (+)-aphidicolin 1988 ·The Journal of Organic Chemistry ·Steven P. Tanis, (unknown), (unknown)	72
12	Furans in synthesis.7. A formal total synthesis of (+/−)-perhydrohistrionicotoxin 1987 ·Tetrahedron Letters ·Steven P. Tanis, (unknown)	20
13	Selective rearrangements of 4a,5-epoxides of 4,4-dimethyl-1,2,3,4,6,8a-hexahydronaphthalenes. 1985 ·Tetrahedron Letters ·Steven P. Tanis, (unknown), Paul G. Williard	1
14	A formal total synthesis of (±)-aphidicolin 1985 ·Tetrahedron Letters ·Steven P. Tanis, (unknown), (unknown)	25
15	Furans in Synthesis. The Preparation of Spiro-Cyclic Systems. 1985 ·Tetrahedron Letters ·Steven P. Tanis, Paul M. Herrinton, (unknown)	8
16	Furans in synthesis. 3. Furans as terminators in cationic cyclization 1983 ·The Journal of Organic Chemistry ·Steven P. Tanis, Paul M. Herrinton	56
17	Furans in Synthesis. The Preparation of (±)-Lactaral 1982 ·Tetrahedron Letters ·Steven P. Tanis, (unknown)	11
18	Nonbleachable rhodopsins retaining the full natural chromophore 1980 ·Journal of the American Chemical Society ·Hiroyuki Akita, Steven P. Tanis, Michael Adams, Valeria Balogh‐Nair, Koji Nakanishi	98
19	A convenient synthesis of stereochemically pure retinoids. The synthesis of 10,14-dimethyl retinals. 1978 ·Tetrahedron Letters ·Steven P. Tanis, (unknown), Koji Nakanishi	12
20	Nasute termite soldier frontal gland secretions. 1. Structure of trinervi-2.beta.,3.alpha.,9.alpha.-triol 9-O-acetate, a novel diterpene from Trinervitermes soldiers 1976 ·Journal of the American Chemical Society ·Glenn D. Prestwich, Steven P. Tanis, James P. Springer, Jon Clardy	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact